Plasminogen activator inhibitor-1 and thrombin activable fibrinolysis inhibitor in patients with type 2 diabetes

被引：0
|
作者：
Blaszkowski, A. [1 ]
Galar, M. [1 ]
Sokolowski, J. [1 ]
Kloczko, J. [1 ]
机构：
[1] Med Univ Bialystok, Bialystok, Poland
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1329
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients
    Lindgren, A
    Lindoff, C
    Norrving, B
    Astedt, B
    Johansson, BB
    STROKE, 1996, 27 (06) : 1066 - 1071
  • [22] Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes
    Yu, Yongzhuo
    Li, Wenxuan
    Xu, Lili
    Wang, Yangang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [23] Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus
    Bayomy, Omar
    Rao, Ajay D.
    Garg, Rajesh
    Vaidya, Anand
    Kotin, Alyssa R.
    Reiber, Beata
    Nijmeijer, Stephanie
    Di Carli, Marcelo F.
    Jerosch-Herold, Michael
    Kwong, Raymond Y.
    Adler, Gail K.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2017, 15 (06) : 269 - 275
  • [24] American ginseng improves plasminogen activator inhibitor-1 concentrations in type 2 diabetes
    Vuksan, V
    Xu, Z
    Sievenpiper, JL
    Stavro, MP
    Beljan-Zdravkovic, U
    Di Buono, M
    Jenkins, AL
    DIABETES, 2001, 50 : A368 - A368
  • [25] Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism
    Erem, Cihangir
    Kocak, Mustafa
    Nuhoglu, Irfan
    Yilmaz, Mustafa
    Ucuncu, Ozge
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (05) : 863 - 868
  • [26] Simvastatin reduces plasma levels of plasminogen activator inhibitor-1 in patients with type 2 diabetes mellitus
    Dharmalingam, S
    Ludwig, S
    Ren, S
    Fenton, JW
    Velthuis, HTE
    Shen, G
    DIABETES, 2001, 50 : A457 - A457
  • [27] PLASMA LEVELS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN PATIENTS WITH TYPE 2 DIABETES AFTER LIPOPOLYSACCHARIDE INJECTION
    Berg, R. M. G.
    Andreasen, A. S.
    Pedersen, B. K.
    Moller, K.
    INTENSIVE CARE MEDICINE, 2009, 35 : 244 - 244
  • [28] Tanshinones Increase Fibrinolysis through Inhibition of Plasminogen Activator Inhibitor-1
    Xiao, Ying-Hong
    Yang, Long-Fei
    Feng, Xue-Chao
    Yang, Hong
    Ma, Tong-Hui
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (05) : 436 - 438
  • [29] Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
    Zaid Al-Hamodi
    Ikram S Ismail
    Riyadh Saif-Ali
    Khaled A Ahmed
    Sekaran Muniandy
    Cardiovascular Diabetology, 10
  • [30] Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
    Al-Hamodi, Zaid
    Saif-Ali, Riyadh
    Ismail, Ikram S.
    Ahmed, Khaled A.
    Muniandy, Sekaran
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
12345